Salamah, Umi (2015) ANALISIS PENGGUNAAN OBAT ANTIKANKER PADA PASIEN KANKER SERVIKS DI RSUD Dr. MOEWARDI SURAKARTA TAHUN 2014. Karya Tulis Ilmiah thesis, Universitas Setia Budi Surakarta.
![]() |
Text
INTISARI.pdf Download (193kB) |
![]() |
Text
FullText.pdf Restricted to Repository staff only Download (1MB) | Request a copy |
Abstract
Cervical cancer is still first disease ranks most common in Indonesian women. Cervical Cancer is a cancer that occurs in the uterine cervix, an area in which the female reproductive organ is the entrance to the uterus located between the womb with a intercourse hole (vaginal). The study purposes were determined the drug are used as anti-cancer and cervical cancer drugs are most widely used in cervical cancer patients with at Dr. Moewardi Hospital Surakarta from January to June 2014. The obtained secondary data were processed and put into a table in Microsoft Office Excel 2007 and then get the imagines of the pattern of anticancer drugs using. The research method was used retrospectively non-experimental descriptive method. The research results was derived that the anticancer drugs are used in cervical cancer patients at Dr. Moewardi Hospital from January to June 2014 are Cisplatin, Fluouracyl, Paclitacel, Carboplatin, Siklophospamid, Trastuzumab, Docetaxel, Gemcitabine, vincristine, Doxorubin. While most widely anticancer drugs used in cervical cancer patients at Dr. Moewardi Hospital Surakarta from January to June 2014 is Cisplatin. Keywords: Cervical Cancer, Anticancer Drugs, Analysis of Drug Use, Dr.Moewardi Hospital
Item Type: | Thesis (Karya Tulis Ilmiah) |
---|---|
Uncontrolled Keywords: | Cervical Cancer, Anticancer Drugs, Analysis of Drug Use, Dr.Moewardi Hospital |
Subjects: | R Medicine > RS Pharmacy and materia medica |
Divisions: | Fakultas Farmasi > Prodi D3 Farmasi |
Depositing User: | magdalena kartika ningsih |
Date Deposited: | 15 Nov 2019 07:03 |
Last Modified: | 15 Nov 2019 07:03 |
URI: | http://repo.setiabudi.ac.id/id/eprint/2182 |
Actions (login required)
![]() |
View Item |